BIOEQUIVALENCE REVIEW PACKAGES OF "FIRST ACCEPTABLE PROTOCOL" TO BE MADE AVAILABLE TO INDUSTRY; OGD LESSENS REQUIREMENTS FOR ALTERNATIVE DRUG SOURCE
Executive Summary
Bioequivalence protocol reviews will be released by FDA's Office of Generic Drugs Bioequivalence Division in an effort to provide information to companies and to reduce multiple protocols sent to the agency.